Ocugen (OCGN) Return on Sales (2014 - 2026)

Ocugen's Return on Sales history runs 9 years deep, the most recent figure standing at 0.23% for Q1 2026.

• Quarterly Return on Sales fell 13.0% year-over-year to 0.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21% (down 7.0% YoY) and the FY2025 annual result came in at 0.45%, down 2.0% from the prior year.
• Return on Sales was 0.23% for Q1 2026 at Ocugen, down from 0.93% in the prior quarter.
• Across five years, Return on Sales topped out at 0.93% in Q4 2025 and bottomed at 0.88% in Q4 2023.
• A 5-year average of 0.24% and a median of 0.18% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales jumped 3588 bps — and 2023, when it plunged 63 bps.
• Ocugen's Return on Sales stood at 0.25% in 2022, then slumped by 252 bps to 0.88% in 2023, then surged by 79 bps to 0.18% in 2024, then surged by 612 bps to 0.93% in 2025, then slumped by 125 bps to 0.23% in 2026.
• Business Quant data shows OCGN's Return on Sales at 0.23% in Q1 2026, 0.93% in Q4 2025, and 0.11% in Q3 2025.